Series A round brings $35mm to Delinia
Delinia Inc. (therapies for autoimmune and inflammatory diseases) raised $35mm through its Series A round co-led by Sofinnova Partners and Atlas Venture.
- Large Molecule
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.